Marex Group’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$133K Hold
100,000
– – ﹤0.01% 1564
2026
Q2
$147K Hold
100,000
– – ﹤0.01% 1042
2026
Q1
$153K Hold
100,000
– – ﹤0.01% 926
2025
Q4
$124K Hold
100,000
– – ﹤0.01% 890
2025
Q3
$202K Buy
100,000
+55,000
+122% +$101K ﹤0.01% 714
2025
Q2
$81K Sell
45,000
-40,000
-47% -$77.1K ﹤0.01% 574
2025
Q1
$181K Hold
85,000
– – ﹤0.01% 582
2024
Q4
$330K Sell
85,000
-65,000
-43% -$518K 0.01% 431
2024
Q3
$1.52M Hold
150,000
– – 0.03% 181
2024
Q2
$675K Buy
+150,000
New +$1.52M 0.02% 262

Other funds holding BMEA

Marex Group's BMEA Position: Q3 2026 in Review

Marex Group held its Biomea Fusion (BMEA) position steady in Q3 2026 at 100,000 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1564.

Marex Group first reported a position in BMEA in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.52M in Q3 2024. 70 funds tracked by Wall St. Rank hold BMEA as of Q3 2026.

  • Marex Group held 100,000 shares of Biomea Fusion worth $133K as of Q3 2026.
  • Marex Group left its Biomea Fusion share count unchanged in Q3 2026.
  • Biomea Fusion made up ﹤0.01% of Marex Group's portfolio in Q3 2026, its #1564 holding.
  • Marex Group first reported a position in Biomea Fusion in Q2 2024 and has held it in 10 quarters since.
  • Marex Group's Biomea Fusion position peaked at $1.52M in Q3 2024.
  • 70 funds tracked by Wall St. Rank held Biomea Fusion as of Q3 2026.

Based on Marex Group's 13F filing for Q3 2026, filed 16 Nov 2026.